There are all kinds of new results involving the covid vaccines and their effects.
Here’s some exciting news about vaccinated people brought by CBSNews.
Now, the online publication mentioned above notes that there’s a study that’s been conducted in the U.K., which is providing some of the first large-scale, real-world data on how well vaccination protects people against catching a “breakthrough” COVID-19 infection.
More than that, the study is also showing how well it protects breakthrough patients from becoming seriously ill. These results are encouraging, according to the publication.
The peer-reviewed study was published Wednesday in The Lancet medical journal.
It’s important to note the fact that this study will be turning out helpful for policymakers and epidemiologists to fill in a significant gap in the understanding of the true efficiency level of three of the major vaccines that are being already used all over the globe.
CBS noted that the U.S. Centers for Disease Control and Prevention does not have good data on how many people catch Covid 19 after being vaccinated.
Just to refresh your memory, they decided back in spring to track only serious, symptomatic breakthrough cases.
The study’s results are in
The British study that we mentioned above, on the other hand, used mass-testing data in order to find how many breakthrough cases there actually are and how sick the patients are getting.
“Among those who did experience a breakthrough infection, the odds of that infection being asymptomatic increased by 63% after one vaccine dose and by 94% after the second dose.”
This is what the authors of the study told The Lancet.
Here’s what the study co-lead author Dr. Claire Steves of King’s College said:
“We are at a critical point in the pandemic as we see cases rising worldwide due to the delta variant. Breakthrough infections are expected and don’t diminish the fact that these vaccines are doing exactly what they were designed to do — save lives and prevent serious illness.”
Stay tuned for more relevant news about the novel coronavirus, its variants, and the viable vaccines.
